Amantadine - Revision history

Danbot: Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T21:57:49Z

Switch SMW query from broadtable to table format for better layout with TOC

← Revisión anterior		Revisión del 21:57 20 mar 2026
Línea 72:		Línea 72:
	\|?Has Route=Route		\|?Has Route=Route
	\|?Has Population=Population		\|?Has Population=Population
	\|format=~~broadtable~~		\|format=table
	\|headers=plain		\|headers=plain
	\|mainlabel=-		\|mainlabel=-

Danbot: Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

2026-03-20T17:25:32Z

Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

← Revisión anterior		Revisión del 17:25 20 mar 2026
Línea 74:		Línea 74:
	\|format=broadtable		\|format=broadtable
	\|headers=plain		\|headers=plain
	\|~~link~~=~~subject~~		\|mainlabel=-
	\|sort=Has Indication		\|sort=Has Indication
	\|limit=50		\|limit=50

Danbot: Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

2026-03-20T16:43:41Z

Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

← Revisión anterior		Revisión del 16:43 20 mar 2026
Línea 61:		Línea 61:
	==Comments==		==Comments==



			==Indications by Condition==
			''The following table is automatically generated from disease/condition pages across WikEM.''

			{{#ask:[[Has DrugName::Amantadine]]
			\|?Has Indication=Indication
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|?Has Route=Route
			\|?Has Population=Population
			\|format=broadtable
			\|headers=plain
			\|link=subject
			\|sort=Has Indication
			\|limit=50
			}}

	==See Also==		==See Also==

ClaireLewis at 16:46, 19 September 2019

2019-09-19T16:46:24Z

← Revisión anterior		Revisión del 16:46 19 sep 2019
Línea 68:		Línea 68:
	<references/>		<references/>

	[[Category:Pharmacology]]		[[Category:Pharmacology]] [[Category:ID]] [[Category:Neurology]]

Humanguy: added metabolism

2017-10-11T18:48:28Z

added metabolism

← Revisión anterior		Revisión del 18:48 11 oct 2017
Línea 53:		Línea 53:
	==Pharmacology==		==Pharmacology==
	*Half-life: 10-25h		*Half-life: 10-25h
	*Metabolism:		*Metabolism: Not appreciably metabolized; small amounts of acetyl metabolite identified
	*Excretion: Renal		*Excretion: Renal

Humanguy at 18:45, 11 October 2017

2017-10-11T18:45:57Z

← Revisión anterior		Revisión del 18:45 11 oct 2017
Línea 1:		Línea 1:
	==Administration==		==Administration==
	*Type: [[Antiviral]], [[anticholinergics]]		*Type: [[Antiviral]], [[anticholinergics]]
	*Dosage Forms:		*Dosage Forms: capsule or tablet, syrup
	*Routes of Administration: Oral		*Routes of Administration: Oral
	*Common Trade Names:		*Common Trade Names: Gocovri

	==Adult Dosing==		==Adult Dosing==

Rossdonaldson1 at 06:50, 22 May 2017

2017-05-22T06:50:24Z

← Revisión anterior		Revisión del 06:50 22 may 2017
Línea 11:		Línea 11:
	===Parkinsonism, extrapyramidal disease===		===Parkinsonism, extrapyramidal disease===
	*100-200 mg BID		*100-200 mg BID

			===[[Neuroleptic malignant syndrome]]===
			*100mg PO initially
			*Titrate up as needed to max dose 200mg q12hr

	==Pediatric Dosing==		==Pediatric Dosing==
Línea 18:		Línea 22:
	===[[Influenza]], >9 years old===		===[[Influenza]], >9 years old===
	*100 mg PO BID		*100 mg PO BID

	~~===[[Neuroleptic malignant syndrome]]===~~
	*100mg PO initially
	*Titrate up as needed to max dose 200mg q12hr

	==Special Populations==		==Special Populations==

Rossdonaldson1: /* Neuroleptic malignant syndrome= */

2017-05-22T06:50:06Z

Neuroleptic malignant syndrome=

← Revisión anterior		Revisión del 06:50 22 may 2017
Línea 19:		Línea 19:
	*100 mg PO BID		*100 mg PO BID

	==[[Neuroleptic malignant syndrome]]===		===[[Neuroleptic malignant syndrome]]===
	*100mg PO initially		*100mg PO initially
	*Titrate up as needed to max dose 200mg q12hr		*Titrate up as needed to max dose 200mg q12hr

Rossdonaldson1 at 06:49, 22 May 2017

2017-05-22T06:49:56Z

← Revisión anterior		Revisión del 06:49 22 may 2017
Línea 6:		Línea 6:

	==Adult Dosing==		==Adult Dosing==
	*Influenza A: 100 mg BID or 200 mg daily PO		===[[Influenza]] A===
	*Parkinsonism, extrapyramidal disease: 100-200 mg BID		*100 mg BID or 200 mg daily PO

			===Parkinsonism, extrapyramidal disease===
			*100-200 mg BID

	==Pediatric Dosing==		==Pediatric Dosing==
	*Influenza, 1-9 years old: 2.2-4.4 mg/kg PO BID		===[[Influenza]], 1-9 years old===
	*Influenza, >9 years old: 100 mg PO BID		*2.2-4.4 mg/kg PO BID

			===[[Influenza]], >9 years old===
			*100 mg PO BID

			==[[Neuroleptic malignant syndrome]]===
			*100mg PO initially
			*Titrate up as needed to max dose 200mg q12hr

	==Special Populations==		==Special Populations==

ClaireLewis: Created page with "==Administration== Type: Antiviral, anticholinergics Dosage Forms: Routes of Administration: Oral Common Trade Names: ==Adult Dosing== *Influenza A: 100 mg BID o..."

2017-02-25T22:49:47Z

Created page with "==Administration== *Type: Antiviral, anticholinergics *Dosage Forms: *Routes of Administration: Oral *Common Trade Names: ==Adult Dosing== *Influenza A: 100 mg BID o..."

Página nueva

==Administration==
*Type: [[Antiviral]], [[anticholinergics]]
*Dosage Forms:
*Routes of Administration: Oral
*Common Trade Names:

==Adult Dosing==
*Influenza A: 100 mg BID or 200 mg daily PO
*Parkinsonism, extrapyramidal disease: 100-200 mg BID

==Pediatric Dosing==
*Influenza, 1-9 years old: 2.2-4.4 mg/kg PO BID
*Influenza, >9 years old: 100 mg PO BID

==Special Populations==
*[[Drug pregnancy categories|Pregnancy Rating]]: C
*Lactation risk: Infant risk cannot be ruled out
*Renal dosing:
**CrCl 30-50 mL/min: 200 mg PO on first day, then 100 mg/day
**CrCl 15-29 mL/min: 200 mg PO on first day, then 100 mg every other day
**CrCl <15 mL/min or on HD: 200mg weekly
*Hepatic dosing: not defined

==Contraindications==
*Allergy to class/drug

==Adverse Reactions==
===Serious===
*CHF, hypotension, dysrhythmia, tachycardia, cardiac arrest
*Pulmonary edema, acute respiratory failure
*Malignant melanoma
*Leukopenia, agranulocytosis, neutropenia
*Neuroleptic malignant syndrome
*Suicidal ideation
===Common===
*Nausea, diarrhea, constipation, lack of appetite
*Headache
*Fatigue, dizziness, confusion, ataxia
*Anxiety, insomnia, depression, irritability, hallucinations, dream disorder
*Orthostatic hypotension
*Peripheral edema

==Pharmacology==
*Half-life: 10-25h
*Metabolism:
*Excretion: Renal

==Mechanism of Action==
*Interferes with the function of viral M2 protein, preventing release of viral nucleic acids into host cell

==Comments==

==See Also==
*[[Influenza]]

==References==
<references/>

[[Category:Pharmacology]]